Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway

Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway

This study aimed to investigate the effect of sesamol (SEM) on the protein kinase A (PKA) pathway in obesity-related hepatic steatosis treatment by using high-fat diet (HFD)-induced obese mice and a palmitic acid (PA)-treated HepG2 cell line. SEM reduced the body weight gain of obese mice and allevi...

Full description

Bibliographic Details
Main Authors: Hai-Yan Xu, Liang Yu, Ji-Hua Chen, Li-Na Yang, Cui Lin, Xiu-Quan Shi, Hong Qin
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Nutrients
Subjects:
sesamol
hepatic steatosis
obesity
lipid metabolism
protein kinase a
Online Access:https://www.mdpi.com/2072-6643/12/2/329

Internet

https://www.mdpi.com/2072-6643/12/2/329

Similar Items